Abbott Laboratories vs. Minerva Neurosciences, Inc
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | NERV | |
|---|---|---|
| Market Cap | $173.21 billion | $158.52 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | NERV | |
|---|---|---|
| Dividend Yield | 2.57% | — |
ABT and NERV split the dividend factors evenly.
Risk & Sentiment
| ABT | NERV | |
|---|---|---|
| Short Interest | 0.57% | 3.52% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, NERV overview, NERV financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.